During the coronavirus disease 2019 (COVID-19) pandemic, the FDA authorized the emergency use of neutralizing monoclonal antibodies (mAbs) to treat mild to moderate COVID-19 patients at risk of progression to a more severe prognosis. This was done in an attempt…
Read More
Next-gen COVID vaccine to make persistent neutralizing antibodies
Scientists and pharmaceutical companies have successfully generated vaccines to fight the coronavirus disease (COVID-19) pandemic. Most of these vaccines are very effective in combating the disease. However, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA virus that has…
Read More
How women in England faced childbirth in the COVID-19 pandemic
Pregnant women have suffered considerable uncertainty during the coronavirus disease 2019 (COVID-19) pandemic. Not only were the effects of the virus on the baby unknown, but social restrictions in place threatened their ability to plan their delivery experience or have…
Read More
What are the challenges of SARS-CoV-2 serosurveillance in COVID-19 vaccine recipients?
Over a year on since the coronavirus disease 2019 (COVID-19) pandemic began, evidence from studies suggests that the deployment of physical preventive measures, including social distancing, lockdowns, face mask usage, and handwashing, are not fully effective in preventing or mitigating…
Read More